Pfizer Inc.

PFE

US7170811035

Pharmaceuticals

Market Closed - Nyse Other stock markets 21:02:00 08/06/2026 BST			After hours 01:00:00
25.62 ^USD	-1.61%		25.88	+1.03%

06-08	AstraZeneca's Obesity Pill Helps Patients Lose Weight in Midstage Trials	DJ
06-08	Pfizer Inc. Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-08-2026 08:00 AM

Pfizer Inc. Reaffirms Earnings Guidance for the Full-Year 2026

Published on 05/05/2026 at 11:45 am BST

S&P Capital IQ

PFIZER INC.

-1.61%

Pfizer Inc. reaffirmed earnings guidance for the Full-Year 2026. For the year, the company expected revenues in a range of $59.5 billion to $62.5 billion.

Latest news about Pfizer Inc.

06-08	AstraZeneca's Obesity Pill Helps Patients Lose Weight in Midstage Trials	DJ
06-08	Pfizer Inc. Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-08-2026 08:00 AM
06-08	Markets Ask AI for Receipts
06-08	U.S. FDA Approves Pfizer?s HYMPAVZI for the Treatment of Two Additional Hemophilia A or B Patient Populations with Significant Medical Need	CI
06-08	Pfizer Gets FDA Expanded Hympavzi Approval	DJ
06-08	Pfizer Says US FDA Expands Hemophilia Drug Approval to Younger Patients	MT
06-08	US FDA approves Pfizer's bleeding disorder drug for children	RE
06-06	Pfizer Presents Detailed Results From Multiple Phase 2b Studies Of Berobenatide And Plans To Advance 10 Phase 3 Studies For Chronic Weight Management And Obesity-Related Comorbidities	CI
06-06	Pfizer's monthly obesity shot has side-effect profile similar to Wegovy in midstage trial	RE
06-04	Data Feed - Faktencheck: Hantavirus-Infektion ist keine Nebenwirkung des COVID-Impfstoffs von Pfizer	RE
06-03	Pfizer Inc. Presents at Jefferies Global Healthcare Conference 2026, Jun-03-2026 02:00 PM
06-03	AlphaSense nearly doubles valuation to $7.5 billion in new funding round	RE
06-03	Market research firm AlphaSense nearly doubles valuation to $7.5 billion in new funding round	RE
06-02	Celcuity plunges after experimental breast cancer treatment data disappoints	RE
06-02	Fulcrum plummets over 50% after scrapping lead sickle-cell drug on FDA concerns	RE

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (47.4%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (26.2%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (24.5%); - other (1.9%). The United States accounts for 60.8% of net sales.

Employees

75,000

Sector

Pharmaceuticals

More about the company